We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
IDEX Q1 Earnings Surpass Estimates, Sales Increase Year Over Year
Read MoreHide Full Article
IDEX Corporation’s (IEX - Free Report) first-quarter 2025 adjusted earnings of $1.75 per share surpassed the Zacks Consensus Estimate of $1.64. The bottom line decreased 7% from the year-ago quarter’s earnings of $1.88 per share. Management projected adjusted earnings to be in the band of $1.18-$1.24 per share in the quarter.
(Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)
IEX’s Revenue Details
IDEX’s net sales of $814.3 million beat the Zacks Consensus Estimate of $811 million. The top line increased 2% year over year. Organic sales decreased 1% year over year. Acquisitions/divestitures had a positive impact on sales of 4%, while foreign currency translation had a negative impact of 1% on sales.
IEX reports net sales under three business segments, the results of which are discussed below:
Net sales from the Fluid & Metering Technologies segment totaled $290.5 million, down 7% year over year. Our estimate for segmental net sales was $293.6 million. Organic sales decreased 4% year over year. Acquisition/divestitures impacted sales by 2%, while foreign currency translation had a negative impact of 1% on sales.
Net sales from the Health & Science Technologies segment totaled $341.5 million, up 10% year over year. Our estimate for segmental net sales was $332.9 million. Organic sales declined 1% year over year. Acquisitions/divestitures had a positive impact on sales of 12%, while foreign currency translation had a negative impact of 1% on sales.
Net sales from the Fire & Safety/Diversified Products segment totaled $184.3 million, which increased 4% year over year. Our estimate for segmental net sales was $177.6 million. Organic sales increased 5% on a year-over-year basis, while foreign currency translation had a negative impact of 1% on sales.
IDEX Corporation Price, Consensus and EPS Surprise
IDEX’s cost of sales increased 0.5% year over year to $445.4 million. The gross profit was $368.9 million, up 3.2% year over year. The gross margin was 45.3% compared with 44.6% in the year-ago quarter.
Selling, general and administrative expenses increased 7.3% year over year to $209.4 million. Adjusted EBITDA was $208.0 million, almost in line with the year-ago quarter. The adjusted EBITDA margin decreased 50 bps year over year to 25.5%.
The operating income was $142.0 million, down 11.9% year over year. The operating margin was 17.4%, down 270 bps year over year. Interest expenses (net) increased 72.3% year over year to $16.1 million.
Balance Sheet and Cash Flow of IDEX
While exiting the first quarter, IDEX’s cash and cash equivalents were $594.1 million compared with $620.8 million at the end of fourth-quarter 2024. Long-term borrowings (net) were $1.84 billion compared with $1.9 billion at the end of fourth-quarter 2024.
In the first quarter of 2025, IDEX generated net cash of $105.7 million from operating activities, down 32.5% from the year-ago period. Capital expenditures were $14.3 million compared with $20 million in first-quarter 2024. In the same period, free cash flow was $91.4 million, down 33.1% year over year.
IDEX paid out dividends totaling $52.4 million in the first three months of 2025, up 8% year over year.
IDEX’s Outlook
For the second quarter, IDEX anticipates adjusted earnings to be in the band of $1.95 - $2.05 per share.
On a GAAP basis, IEX predicts earnings to be in the range of $1.60 - $1.72 per share. It expects organic sales to increase in the range of 0-2% from the year-ago reading.
For 2025, the company has reaffirmed its guidance. IDEX anticipates adjusted earnings to be in the band of $8.10-$8.45 per share. The figure indicates an increase from earnings of $7.89 per share reported in 2024. On a GAAP basis, earnings are predicted to be in the band of $6.56-$6.96 per share.
Organic sales are predicted to increase in the range of 1-3%.
AZZ Inc. (AZZ - Free Report) came out with quarterly earnings of $0.98 per share, beating the Zacks Consensus Estimate of $0.95. This compares with earnings of $0.93 per share a year ago.
AZZ reported revenues of $351.88 million, missing the consensus estimate by 3.77%. This compares with year-ago revenues of $366.5 million.
Valmont Industries (VMI - Free Report) reported revenues of $969.31 million in the first quarter of 2025, declining 0.9% on a year-over-year basis. Earnings per share of $4.32 for the same period compare with $4.32 a year ago.
The reported revenues compare with the Zacks Consensus Estimate of $975.6 million. The company delivered an earnings surprise of 1.89%, with the consensus estimate being $4.24 per share.
Pentair plc (PNR - Free Report) came out with quarterly earnings of $1.11 per share in the first quarter of 2025, beating the Zacks Consensus Estimate of $1.01. This compares with earnings of $0.94 per share a year ago.
Pentair posted revenues of $1.01 billion for the quarter, surpassing the consensus estimate by 2.68%. This compares with year-ago revenues of $1.02 billion.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
IDEX Q1 Earnings Surpass Estimates, Sales Increase Year Over Year
IDEX Corporation’s (IEX - Free Report) first-quarter 2025 adjusted earnings of $1.75 per share surpassed the Zacks Consensus Estimate of $1.64. The bottom line decreased 7% from the year-ago quarter’s earnings of $1.88 per share. Management projected adjusted earnings to be in the band of $1.18-$1.24 per share in the quarter.
(Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)
IEX’s Revenue Details
IDEX’s net sales of $814.3 million beat the Zacks Consensus Estimate of $811 million. The top line increased 2% year over year. Organic sales decreased 1% year over year. Acquisitions/divestitures had a positive impact on sales of 4%, while foreign currency translation had a negative impact of 1% on sales.
IEX reports net sales under three business segments, the results of which are discussed below:
Net sales from the Fluid & Metering Technologies segment totaled $290.5 million, down 7% year over year. Our estimate for segmental net sales was $293.6 million. Organic sales decreased 4% year over year. Acquisition/divestitures impacted sales by 2%, while foreign currency translation had a negative impact of 1% on sales.
Net sales from the Health & Science Technologies segment totaled $341.5 million, up 10% year over year. Our estimate for segmental net sales was $332.9 million. Organic sales declined 1% year over year. Acquisitions/divestitures had a positive impact on sales of 12%, while foreign currency translation had a negative impact of 1% on sales.
Net sales from the Fire & Safety/Diversified Products segment totaled $184.3 million, which increased 4% year over year. Our estimate for segmental net sales was $177.6 million. Organic sales increased 5% on a year-over-year basis, while foreign currency translation had a negative impact of 1% on sales.
IDEX Corporation Price, Consensus and EPS Surprise
IDEX Corporation price-consensus-eps-surprise-chart | IDEX Corporation Quote
IDEX’s Margin Profile
IDEX’s cost of sales increased 0.5% year over year to $445.4 million. The gross profit was $368.9 million, up 3.2% year over year. The gross margin was 45.3% compared with 44.6% in the year-ago quarter.
Selling, general and administrative expenses increased 7.3% year over year to $209.4 million. Adjusted EBITDA was $208.0 million, almost in line with the year-ago quarter. The adjusted EBITDA margin decreased 50 bps year over year to 25.5%.
The operating income was $142.0 million, down 11.9% year over year. The operating margin was 17.4%, down 270 bps year over year. Interest expenses (net) increased 72.3% year over year to $16.1 million.
Balance Sheet and Cash Flow of IDEX
While exiting the first quarter, IDEX’s cash and cash equivalents were $594.1 million compared with $620.8 million at the end of fourth-quarter 2024. Long-term borrowings (net) were $1.84 billion compared with $1.9 billion at the end of fourth-quarter 2024.
In the first quarter of 2025, IDEX generated net cash of $105.7 million from operating activities, down 32.5% from the year-ago period. Capital expenditures were $14.3 million compared with $20 million in first-quarter 2024. In the same period, free cash flow was $91.4 million, down 33.1% year over year.
IDEX paid out dividends totaling $52.4 million in the first three months of 2025, up 8% year over year.
IDEX’s Outlook
For the second quarter, IDEX anticipates adjusted earnings to be in the band of $1.95 - $2.05 per share.
On a GAAP basis, IEX predicts earnings to be in the range of $1.60 - $1.72 per share. It expects organic sales to increase in the range of 0-2% from the year-ago reading.
For 2025, the company has reaffirmed its guidance. IDEX anticipates adjusted earnings to be in the band of $8.10-$8.45 per share. The figure indicates an increase from earnings of $7.89 per share reported in 2024. On a GAAP basis, earnings are predicted to be in the band of $6.56-$6.96 per share.
Organic sales are predicted to increase in the range of 1-3%.
IEX’s Zacks Rank
The company currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Performance of Other Companies
AZZ Inc. (AZZ - Free Report) came out with quarterly earnings of $0.98 per share, beating the Zacks Consensus Estimate of $0.95. This compares with earnings of $0.93 per share a year ago.
AZZ reported revenues of $351.88 million, missing the consensus estimate by 3.77%. This compares with year-ago revenues of $366.5 million.
Valmont Industries (VMI - Free Report) reported revenues of $969.31 million in the first quarter of 2025, declining 0.9% on a year-over-year basis. Earnings per share of $4.32 for the same period compare with $4.32 a year ago.
The reported revenues compare with the Zacks Consensus Estimate of $975.6 million. The company delivered an earnings surprise of 1.89%, with the consensus estimate being $4.24 per share.
Pentair plc (PNR - Free Report) came out with quarterly earnings of $1.11 per share in the first quarter of 2025, beating the Zacks Consensus Estimate of $1.01. This compares with earnings of $0.94 per share a year ago.
Pentair posted revenues of $1.01 billion for the quarter, surpassing the consensus estimate by 2.68%. This compares with year-ago revenues of $1.02 billion.